WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹5.13 Cr | ₹4.95 Cr | ₹3.95 Cr | ₹3.44 Cr | ₹0.21 Cr |
What is the latest Total Non-Current Liabilities ratio of WINDLAS BIOTECH ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹5.13 Cr |
| Mar2025 | ₹4.95 Cr |
| Mar2024 | ₹3.95 Cr |
| Mar2023 | ₹3.44 Cr |
| Mar2022 | ₹0.21 Cr |
How is Total Non-Current Liabilities of WINDLAS BIOTECH Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.13 Cr | 3.63 | |
| Mar2025 | ₹4.95 Cr | 25.46 | |
| Mar2024 | ₹3.95 Cr | 14.84 | |
| Mar2023 | ₹3.44 Cr | 1,513.62 | |
| Mar2022 | ₹0.21 Cr | - | |
Compare Total Non-Current Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,955.9 Cr | 12.5% | 11.8% | 2.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 12.5% |
11.8% |
2.7% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses